SCYNEXIS (SCYX)
Develops antifungal and rare-disease drug candidates under a GSK licensing model.
$4.54
vs last close−0.32 (−6.58%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 51.74% | 5.15M shares | |
|---|---|---|---|
| 39 holders · as of Jun 30, 2026 | |||
| Insiders | 3.67% | 365.4K shares | |
| 10 holders · as of Sep 22, 2026 | |||
| Other | 44.59% | 4.44M shares | |
| remainder | |||
9.95M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (9.95M in the company's Sep 23, 2026 report, 6.29M elsewhere); stakes use the report.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
13F, as of Jun 30, 2026
39 holders · 5.15M shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Great Point Partners LLC | 944.3K | 9.49% | Aug 14, 2026 | |
| Squadron Capital Management LLC | 756.9K | 7.61% | Aug 14, 2026 | |
| Propel Bio Management, LLC | 543.5K | 5.46% | Aug 13, 2026 | |
| Adage Capital Partners GP, L.L.C. | 543.5K | 5.46% | Aug 14, 2026 | |
| Woodline Partners LP | 387.5K | 3.89% | Aug 14, 2026 | |
| Vanguard Capital Management LLC | 296.7K | 2.98% | Aug 13, 2026 | |
| Avidity Partners Management LP | 260.2K | 2.62% | Aug 14, 2026 | |
| Kingdon Capital Management, L.L.C. | 247.8K | 2.49% | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Adage Capital Management, L.P. | 9.99% | 1.04M | 13G | Aug 12, 2026 |
| Great Point Partners, LLC | 9.99% | 13G | Apr 7, 2026 | |
| Avidity Partners Management LP | 9.90% | 13G | Feb 17, 2026 | |
| Squadron Master Fund LP | 9.60% | 13G | Apr 8, 2026 | |
| Federated Hermes, Inc. | 8.42% | 13G | Jan 8, 2026 | |
| CVI Investments, Inc. | 6.20% | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 1, 2026 | Gonzalez David Angulodirector, officer: Chief Executive Officer | Purchase · 2 lots | 217,390 | $1.20 | 1,465,821 |
House and Senate disclosures
Not reported.